Claude Mythos Preview vs GPT-Rosalind (OpenAI)
Which one should you pick? Here's the full breakdown.
Claude Mythos Preview
Anthropic's most capable model -- a gated research preview via Project Glasswing, cybersecurity-specialized. 73% success on expert CTF tasks, 32-step autonomous network attacks. Not generally available.
GPT-Rosalind (OpenAI)
OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
| Category | Claude Mythos Preview | GPT-Rosalind (OpenAI) |
|---|---|---|
| Ease of Use | 2.0 | 3.0 |
| Output Quality | 10.0 | 9.0 |
| Value | 5.0 | 7.0 |
| Features | 9.0 | 8.0 |
| Overall | 6.5 | 6.8 |
Pricing Comparison
| Feature | Claude Mythos Preview | GPT-Rosalind (OpenAI) |
|---|---|---|
| Free Tier | No | No |
| Starting Price | Invite only | Invite only |
Which Should You Pick?
Pick Claude Mythos Preview if...
- ✓Higher output quality (10 vs 9)
- ✓More features (9 vs 8)
Partner organizations in Project Glasswing doing cybersecurity research, defensive red-teaming, threat intelligence, or large-scale vulnerability triage. If your use case is legitimate cybersecurity and you have enterprise Anthropic contact, ask about Glasswing admission.
Visit Claude Mythos PreviewPick GPT-Rosalind (OpenAI) if...
- ✓Easier to use (3 vs 2)
- ✓Better value for money (7/10)
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Visit GPT-Rosalind (OpenAI)Our Verdict
Claude Mythos Preview and GPT-Rosalind (OpenAI) are extremely close overall. Your choice comes down to specific needs -- Claude Mythos Preview is better for partner organizations in project glasswing doing cybersecurity research, defensive red-teaming, threat intelligence, or large-scale vulnerability triage, while GPT-Rosalind (OpenAI) works best for researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.